Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
about
Cardiovascular risk assessment in rheumatoid arthritis - controversies and the new approachManaging cardiovascular risk in patients with inflammatory arthritis: practical considerationsConcomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis.The Prevalence of Atherosclerosis in Those with Inflammatory Connective Tissue Disease by Race, Age, and Traditional Risk Factors.Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care setting.Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.Improving cardiovascular health and metabolic comorbidities in patients with psoriatic arthritis"Official View" on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus Statements.Cardiovascular disease in patients with rheumatoid arthritis.Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis.Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches.Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis.Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis.Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management.Simple screening tools predict death and cardiovascular events in patients with rheumatic disease.Editorial: Do We Need a Disease-Specific Cardiovascular Risk Calculator for Patients With Rheumatoid Arthritis?
P2860
Q26738461-070EC602-4D32-4080-BBA3-FF0219D102ABQ27694518-B1F168EA-077B-4573-A3B9-1017E6A51535Q33725505-303FFE9D-53C8-4C13-B707-3B3777F115D7Q34512225-0FA8CABE-C276-45B6-A231-14DBA4D7C3EAQ35763883-EAA6DF58-2C3B-4B28-85A5-4B89ED6654C3Q36320021-3550872B-9D3E-4A70-AA3B-08C5723BF6A1Q36843650-97566DC8-963A-491E-AE86-72A649FEEF72Q38777227-B9A9D956-BC7B-4D2A-93B4-9C4DB62871E8Q38950371-B5BD7AD0-C6B1-49E1-B424-2F7D5F228281Q39020908-D8CEEB62-E72F-403D-8B30-5EBA4DD9B788Q39210337-245F0FE0-5717-4779-894D-A2A5EF5BC702Q45953636-4CBB5AA8-EADA-4024-9241-39C6213DAAF8Q46089585-2391D206-767C-4750-9EBE-EE91164669DBQ47817154-CD46E131-DA9F-4035-BE9F-0829A45DF2A7Q47988471-293B3B34-2C77-476A-BF5E-A041103E64C7Q48152632-6CE4245F-1497-487B-B71C-92F8B0C92555Q57751019-1345EE2D-EC16-4357-862C-B7E37C1A4C16
P2860
Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Derivation and internal valida ...... North America Registry Study.
@en
type
label
Derivation and internal valida ...... North America Registry Study.
@en
prefLabel
Derivation and internal valida ...... North America Registry Study.
@en
P2093
P2860
P356
P1476
Derivation and internal valida ...... North America Registry Study.
@en
P2093
D H Solomon
J Greenberg
J M Kremer
J R Curtis
M E Farkouh
P2860
P304
P356
10.1002/ART.39195
P577
2015-05-01T00:00:00Z